Article
[Efficacy and safety of gilteritinib-based combination therapy bridging allo-HSCT in relapsed or refractory acute myeloid leukemia patients with positive FLT3-ITD mutation].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 14 Apr 2024
Xu Y, Zhang J, Xue S L, Miao M, Wang Y, Chen S N, Qiu H Y, Wu D P
Abstract excerpt
Objective: This study aims to evaluate the safety and effectiveness of gilteritinib (Gilt) -based combination therapy bridging allo-HSCT for FLT3-ITD(+) R/R AML. Additionally, it aims to assess the impact of Gilt maintenance therapy on the prognosis of patients after allo-HSCT. Methods: The clinical data of 26 patients with FLT3-ITD(+) R/R AML treated at the First Affiliated Hospital of Soochow University from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.